Business Wire

PSA unboXed Collaborates with Amperesand on Solid-state Transformer Technology Trials for Sustainable Electrification at Singapore’s Port

Share

PSA unboXed, the external innovation and corporate venture capital arm of PSA International (PSA), and Amperesand, a grid infrastructure solutions provider, announced today a collaborative trial focused on enhancing port decarbonisation and promoting sustainable logistics practices.

This partnership involves a pilot trial of Amperesand’s solid-state transformer (SST) technology at Singapore’s port, as part of PSA's planned upcoming charging facilities for its fleet of electric prime movers.

Amperesand’s SST technology provides efficient and safe high-power charging infrastructure for PSA’s electric fleet and is natively intelligent for energy monitoring and management.

The SST solutions feature silicon carbide (SiC) devices and proprietary high-frequency modules, ensuring power flow with higher efficiency and reduced grid strain in a compact form factor. Amperesand’s technology is natively bi-directional and intelligent, allowing optimal energy routing and advanced applications such as vehicle-to-grid. The modular and scalable design enables PSA to manage its electric vehicle charging facilities with greater flexibility, distributing power economically across the facility's high-capacity dispensers.

This partnership will commence with a one-year Proof of Value (PoV) that is targeted to start in mid-2025. The PoV is aimed at gathering data on the functionality and validating the performance and cost of Amperesand’s SST in PSA’s fleet charging application, with the potential to support further port electrification.

“This initiative with Amperesand aligns with our broader objective of integrating innovative technologies to future-proof our infrastructure. By evaluating solid-state transformer technology at PSA Singapore, we aim to gain strategic insights that could inform our approach to sustainable electrification and operational resilience in the future,” said Mr Nelson Quek, Regional CEO Southeast Asia, PSA International.

Mr Alvin Foo, Head of Technology and Sustainability Solutions, PSA Singapore & Head of PSA unboXed, said, “Following our preliminary assessment, PSA finds Amperesand’s SST technology promising and I look forward to the positive outcomes from the PoV trial as it has the potential to enhance our efforts in sustainable electrification at the port. PSA will continue to explore innovative technologies such as SST, as we collaborate with like-minded partners to deliver long-term value for our customers and stakeholders.”

“PSA has long been recognized worldwide as a leader in port operations. With PSA's expertise and support, we look forward to demonstrating the value of Amperesand’s SST solutions in providing intelligent grid interfaces for fleet charging applications,”said Mr Phil Inagaki, Interim CEO Amperesand.

About PSA unboXed

The Corporate Venture Capital arm of PSA International, PSA unboXed is committed to accelerating technological advancements and fostering groundbreaking solutions within the global supply chain and port operations industry. Leveraging PSA International’s extensive expertise and expansive global network, PSA unboXed aims to drive transformational growth, enhance operational efficiency, and promote sustainability across the logistics ecosystem. With a strategic and agile approach, PSA unboXed is uniquely positioned to invest in and nurture the next generation of pioneering companies, shaping the future of logistics and transportation. Visit us at unboxed.globalpsa.com, or follow us on LinkedIn and Facebook (@psaunboxed).

About Amperesand

Amperesand’s infrastructure solutions, powered by novel solid-state transformer (SST) technology, enable efficient, intelligent, and resilient electrification. Amperesand's core SST technology was pioneered at the Energy Research Institute at Nanyang Technological University (NTU). Amperesand was established in 2023. For more information, visit www.amperesand.io. Contact us at info@amperesand.io.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241022552697/en/

Contacts

Media Contact
PSA unboXed
Matthew Webster
Assistant Vice-President (Branding & Media), Corporate Communications, PSA
Singapore / PSA unboXed
mattheww@globalpsa.com

Amperesand
Dickson Thian
Chief of Staff, Amperesand Pte. Ltd.
dickson@amperesand.io

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Copeland and Daikin Cooperation Brings Solutions to European Customers15.12.2025 14:00:00 CET | Press Release

Copeland and Daikin, two global leaders in heating, ventilation and air conditioning (HVAC) solutions, today announced the expansion of their existing joint venture into Europe. Through this cooperation, the companies will introduce advanced inverter swing rotary compressors, power electronics and controls designed specifically for European residential heat pumps. This collaboration underscores both companies’ commitment to accelerate the energy transition, with heat pumps recognized by industry reports as a cornerstone technology helping to reduce global carbon dioxide emissions by an estimated 500 million tons by 2030. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215625806/en/ (Left to right) Ross B. Shuster, CEO of Copeland and Jiro Tomita, executive associate officer of Daikin As Europe rapidly transitions away from fossil fuels, the demand for residential heat pumps is growing in parallel with ambitious sustainabil

Visa Unveils New Global Stablecoins Advisory Practice15.12.2025 13:00:00 CET | Press Release

Visa (NYSE: V), a global leader in digital payments, today announced the launch of its Stablecoins Advisory Practice. The new value-added service offering by Visa Consulting & Analytics (VCA) provides actionable insights and recommendations to guide banks, fintechs, merchants, and businesses of all sizes on market fit, strategy, and implementation. As the stablecoin market cap surpasses $250 billion, Visa’s settlement volume has accelerated, reaching a $3.5 billion annualized run rate as of November 30. Businesses are turning to Visa’s new Stablecoins Advisory Practice to unlock growth opportunities. “Putting our members first has always been our mission, and we’re committed to exploring innovations that strengthen financial health and convenience for those we serve. Stablecoins may represent an opportunity to enhance speed and lower cost in payments, so with the support of Visa, we are evaluating how this technology could fit into our broader strategy to deliver meaningful value to ou

SK Capital Announces Definitive Agreement to Invest in Swixx BioPharma AG to Drive the Next Phase of Growth and Global Expansion15.12.2025 12:30:00 CET | Press Release

SK Capital Partners, LP (“SK Capital”), a New York-based private investment firm focused on the life sciences, specialty materials, and ingredients sectors, today announced that its affiliate has reached an agreement to invest in Swixx BioPharma AG (“Swixx” or the “Company”) to accelerate the Company’s next phase of growth and global expansion. The investment values the Company in excess of EUR €1.5 billion. Swixx is the global leader in rest-of-world pharmaceutical commercialization services dedicated to delivering innovative, life-saving medications to underserved and hard-to-reach markets. Stuart Swanson and Petr Němec, Swixx’s Co-Founders, and Jean-Michel Lespinasse and Petr Pipal, Swixx’s CEO and CFO, respectively, will all retain significant ownership stakes in Swixx as part of the transaction. Existing institutional investors HBM Healthcare Investments, a Swiss-listed investment company for the global healthcare market, and Mérieux Equity Partners, a leading healthcare-specializ

Safe Software Recognized as a Niche Player in 2025 Gartner® Magic Quadrant™ for Data Integration Tools15.12.2025 12:00:00 CET | Press Release

Safe Software, a global leader in data integration and transformation, has once again been recognized in the 2025 Gartner® Magic Quadrant™ for Data Integration Tools, marking the sixth consecutive year the company has been included in this prestigious report. Safe Software’s FME Platform has evolved well beyond its geospatial roots to become the only All-Data, Any-AI Integration Platform, empowering organizations worldwide to connect all data, applications, and AI technologies anywhere, at any scale, and with complete flexibility. With a community of more than 200,000 enthusiastic users and 25,000+ organizations in over 125 countries, FME continues to redefine data integration by delivering a no-code enterprise solution that unifies data movement, automation, and AI connectivity. “Our continued recognition reflects the trust of our customers and the innovation of our team,” said Don Murray, CEO and Co-Founder of Safe Software. “We’re proud to help organizations integrate data seamlessl

GENESIS Pharma announces a new partnership with Otsuka Pharmaceutical Europe Ltd. for the commercialization of donidalorsen for hereditary angioedema in Central and Eastern Europe15.12.2025 10:00:00 CET | Press Release

ANNOUNCEMENT FOR EUROPEAN MEDICAL & PHARMACEUTICAL TRADE MEDIA AND EUROPEAN FINANCIAL MEDIA ONLY GENESIS Pharma, a regional biopharma company focused on the commercialization of innovative medicines in Central and Eastern Europe, announces an exclusive agreementwithOtsuka Pharmaceutical Europe Ltd. (OPEL), the European operation of global healthcare company Otsuka Pharmaceutical Co., Ltd., for donidalorsen. Under the terms of the agreement, GENESIS Pharma will exclusively distribute and commercializedonidalorsen in fourteen markets: Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Greece, Hungary, Latvia, Lithuania, Malta, Poland, Romania, Slovakia and Slovenia. In November 2025, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for donidalorsen in the routine prevention of recurrent attacks of hereditary angioedema (HAE) in adults and adolescents aged 12 years and older. The CHMP opinion is c

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye